2024 Q4 Form 10-Q Financial Statement

#000173112224001835 Filed on November 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $228.3K
YoY Change 553.76%
Operating Profit -$228.3K
YoY Change 553.76%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$291.8K
YoY Change 278.65%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$0.01
COMMON SHARES
Basic Shares Outstanding 64.87M shares 64.37M shares
Diluted Shares Outstanding 62.44M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.452K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $0.00
Prepaid Expenses $780.00
Receivables
Other Receivables
Total Short-Term Assets $2.232K
YoY Change -98.96%
LONG-TERM ASSETS
Property, Plant & Equipment $20.83K
YoY Change -15.69%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $20.83K
YoY Change -15.69%
TOTAL ASSETS
Total Short-Term Assets $2.232K
Total Long-Term Assets $20.83K
Total Assets $23.07K
YoY Change -90.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.276M
YoY Change 16.95%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.276M
Total Long-Term Liabilities
Total Liabilities $2.276M
YoY Change 16.95%
SHAREHOLDERS EQUITY
Retained Earnings -$4.467M
YoY Change 35.44%
Common Stock $64.87K
YoY Change 17.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.253M
YoY Change
Total Liabilities & Shareholders Equity $23.07K
YoY Change -90.36%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$291.8K
YoY Change 278.65%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Registrant Name
EntityRegistrantName
SENTIENT BRANDS HOLDINGS INC.
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
52698 usd
CY2024Q3 us-gaap Legal Fees
LegalFees
40300 usd
CY2023Q3 us-gaap Legal Fees
LegalFees
32417 usd
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei City Area Code
CityAreaCode
646
dei Local Phone Number
LocalPhoneNumber
202-2897
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
64870518 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1452 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1299 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
780 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8453 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
0 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
150000 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
64870518 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64870518 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56140518 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56140518 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
64871 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
56141 usd
CY2024Q3 us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
2232 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
159752 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23742 usd
CY2024Q3 us-gaap Assets
Assets
23066 usd
CY2023Q4 us-gaap Assets
Assets
183494 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
725066 usd
CY2024Q3 snbh Subscriptions Payable
SubscriptionsPayable
105000 usd
CY2023Q4 snbh Subscriptions Payable
SubscriptionsPayable
0 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
544691 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
533191 usd
CY2024Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
809047 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
859047 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2275823 usd
CY2024Q3 us-gaap Liabilities
Liabilities
2275823 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2080447 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1542429 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4467129 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3533380 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
150 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
50 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
0 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
100 usd
CY2023Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
69 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
0 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1056 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
43026 usd
us-gaap Legal Fees
LegalFees
409178 usd
us-gaap Legal Fees
LegalFees
64318 usd
CY2024Q3 us-gaap Management Fee Expense
ManagementFeeExpense
19200 usd
CY2023Q3 us-gaap Management Fee Expense
ManagementFeeExpense
0 usd
us-gaap Management Fee Expense
ManagementFeeExpense
140000 usd
us-gaap Management Fee Expense
ManagementFeeExpense
0 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001358633
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-34861
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-3765910
dei Entity Address Address Line1
EntityAddressAddressLine1
590 Madison Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
21st Floor
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20834 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
817055 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2117304 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2117304 usd
CY2024Q3 snbh Common Stock To Be Issued
CommonStockToBeIssued
68054 usd
CY2023Q4 snbh Common Stock To Be Issued
CommonStockToBeIssued
0 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-2252757 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1933810 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23066 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
183494 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
CY2024Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
0 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18766 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2430 usd
CY2024Q3 snbh Write Off Excess Inventory
WriteOffExcessInventory
150000 usd
CY2023Q3 snbh Write Off Excess Inventory
WriteOffExcessInventory
0 usd
snbh Write Off Excess Inventory
WriteOffExcessInventory
150000 usd
snbh Write Off Excess Inventory
WriteOffExcessInventory
0 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
228266 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
34916 usd
us-gaap Operating Expenses
OperatingExpenses
742204 usd
us-gaap Operating Expenses
OperatingExpenses
118072 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-228266 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-34916 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-742204 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-117972 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
63575 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
42158 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
191545 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
124659 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-291841 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-77074 usd
us-gaap Net Income Loss
NetIncomeLoss
-933749 usd
us-gaap Net Income Loss
NetIncomeLoss
-242631 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.005
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.005
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.001
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.001
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.015
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.015
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.004
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.004
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62435195 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62435195 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54698779 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54698779 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61658870 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61658870 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54560699 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54560699 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1933810 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
258000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-416754 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-2092564 usd
CY2024Q2 snbh Common Stock Issued In Payment Of Past Services
CommonStockIssuedInPaymentOfPastServices
14998 usd
CY2024Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
82750 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
179000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
68054 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-225154 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1972916 usd
CY2024Q3 snbh Common Stock Issued In Payment Of Past Services
CommonStockIssuedInPaymentOfPastServices
12000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-291841 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-2252757 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1642976 usd
CY2023Q1 snbh Common Stock Issued In Payment Of Past Services
CommonStockIssuedInPaymentOfPastServices
127000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
13900 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-75845 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1577921 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-89711 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1667632 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
38000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-77074 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1706707 usd
us-gaap Net Income Loss
NetIncomeLoss
-933749 usd
us-gaap Net Income Loss
NetIncomeLoss
-242631 usd
us-gaap Depreciation
Depreciation
2908 usd
us-gaap Depreciation
Depreciation
2909 usd
snbh Common Stock Issued In Payments Of Past Services
CommonStockIssuedInPaymentsOfPastServices
26998 usd
snbh Common Stock Issued In Payments Of Past Services
CommonStockIssuedInPaymentsOfPastServices
127000 usd
snbh Write Off Excess Inventory
WriteOffExcessInventory
150000 usd
snbh Write Off Excess Inventory
WriteOffExcessInventory
0 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
340750 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
13900 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-0 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-24539 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-7673 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
110073 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
13489 usd
snbh Increase Decrease In Stock Subscription
IncreaseDecreaseInStockSubscription
105000 usd
snbh Increase Decrease In Stock Subscription
IncreaseDecreaseInStockSubscription
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-190347 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-60794 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-0 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
0 usd
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
0 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
11500 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
22795 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
179000 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
38000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
190500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
60795 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
153 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1299 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1048 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1452 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1049 usd
us-gaap Interest Paid Net
InterestPaidNet
79950 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
snbh Conversion Of Note Payable And Accrued Interests Into Common Stock To Be Issued
ConversionOfNotePayableAndAccruedInterestsIntoCommonStockToBeIssued
68054 usd
snbh Conversion Of Note Payable And Accrued Interests Into Common Stock To Be Issued
ConversionOfNotePayableAndAccruedInterestsIntoCommonStockToBeIssued
0 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4467129 usd
us-gaap Profit Loss
ProfitLoss
933749 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-190347 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_z6fGZaiNVW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i><span id="xdx_865_zX8DvSHG62t8">Uses of estimates in the preparation of financial statements</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses during each reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Inventory Write Down
InventoryWriteDown
63477 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
150000 usd
CY2024Q3 snbh Additional Charges On Inventories
AdditionalChargesOnInventories
150000 usd
CY2024Q3 snbh Reduceing Value Of Inventories
ReduceingValueOfInventories
0 usd
CY2024Q2 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
3272031 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2024Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
2000000 shares
CY2024Q2 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
68054 usd
CY2024Q2 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
3272031 shares
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
938097 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
605817 usd
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
938097 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
605817 usd
CY2024Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q1 snbh Cash Payments And Shares Description
CashPaymentsAndSharesDescription
the Company engaged a consultant pursuant to which the consultant was to receive as consideration for services in accordance with a payment schedule three cash payments of $10,000 for a total of $30,000 and three issuances of 1,000,000 shares of the Company’s common stock for a total of 3,000,000 shares. During the first quarter of 2024, the consultant received two separate cash payments of $10,000 for a total of $20,000 and two separate issuances of 1,000,000 shares of the Company’s common stock.
CY2024Q3 snbh Liability For Subscriptions Payable
LiabilityForSubscriptionsPayable
105000 usd

Files In Submission

Name View Source Status
0001731122-24-001835-index-headers.html Edgar Link pending
0001731122-24-001835-index.html Edgar Link pending
0001731122-24-001835.txt Edgar Link pending
0001731122-24-001835-xbrl.zip Edgar Link pending
e6116_10q.htm Edgar Link pending
e6116_ex31-1.htm Edgar Link pending
e6116_ex31-2.htm Edgar Link pending
e6116_ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
e6116_10q_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
snbh-20240930.xsd Edgar Link pending
snbh-20240930_def.xml Edgar Link unprocessable
snbh-20240930_lab.xml Edgar Link unprocessable
snbh-20240930_cal.xml Edgar Link unprocessable
snbh-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable